市場調査レポート

商品コード

輸血診断市場の2028年までの予測-製品、アプリケーション、エンドユーザー別の世界分析

Blood Transfusion Diagnostics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product, Application, and End User

出版日: 2022年07月27日 | 発行: The Insight Partners

| ページ情報: 英文 183 Pages | 納期: 即納可能

価格

PDF (Single User License)

USD 4,550 713,258円

レポートPDFを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は一度のみ可能です。印刷したもののご利用はPDFのライセンス保持者に限定されます。

PDF (Site License)

USD 6,550 1,026,778円

レポートPDFを同一事業所（所在地）内のすべての方にご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷回数に制限はありません。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprise License)

USD 8,550 1,340,298円

レポートPDFを企業内すべての方に使用頂けるライセンスです。PDF内のテキスト等のコピーは可能です。PDFの印刷回数に制限はありません。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=156.76円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

輸血診断の世界市場は、2021年の40億9693万米ドルから、2028年には64億8375万米ドルに拡大すると予測されています。2022年から2028年までのCAGRは6.9％と推定されています。本レポートでは、市場成長を促進する一般的な動向と要因について取り上げています。

輸血診断の世界市場の成長は、慢性疾患の急増と臓器移植手術の増加による輸血の必要性に起因しています。しかし、輸血業務に関連する問題が市場全体の成長を妨げています。

輸血診断とは、患者に輸血する前に血液や血液成分に対して行う検査のことを指します。輸血は、提供された血液または血液成分を、静脈ライン（IV）を通じて患者の体内に注入する一般的な処置です。輸血される血液は、副作用や感染症を防ぐために、血液型の識別を行う「血液型検査」と、病気の検出検査を行う「血液スクリーニング」を行う必要があります。輸血前の血液スクリーニングは、HIV、B型肝炎、C型肝炎、ジカ熱など、さまざまなウイルスや感染症を特定するための機器やキット、試薬によって行われます。

国立がん予防研究機関（NICPR）とインド医学研究評議会（ICMR）が発表したデータによると、インドにおけるがんの年間有病率は～225万人と推定され、多数の外科手術につながっています。

B-サラセミアにおける輸血の課題」と題された2019年の研究によると、輸血依存性B-サラセミア（TDT）患者は毎年約26,000人生まれ、その約90％は低・中所得国で発生しています。鎌状赤血球症を含むヘモグロビン異常症は、アフリカ、アジア、中東、インド亜大陸、地中海沿岸地域で流行している疾患です。現在、欧州では、最も一般的な希少遺伝性疾患となっています。ヘモグロビン異常症は、移住により、先住民族ではない北米や北欧、南欧の先住民族の国の一部で、ますます一般的になってきています。そのため、B-サラセミアの有病率が増加しました。英国のNational Haemoglobinopathy Registryには約800人のサラセミア患者が登録されており、そのうち約500人が定期的に輸血を受けています。そのため、心臓手術などの各種外科手術や侵襲的な手術において、輸血診断が広く用いられています。

がん、循環器疾患、腎臓疾患などの慢性疾患は、世界的に人間の主な死因となっています。これらの疾患は、一般的に外科手術によって治療されますが、その際、過剰な出血を伴う可能性があります。そのため、患者さんの血液濃度を維持するために新鮮な血液を輸血します。輸血診断装置は、輸血や再輸血の工程で使用されます。したがって、輸血診断の世界市場は、慢性疾患の急激な増加とともに上昇しています。

輸血診断の世界市場は、製品によって機器・キットと試薬に二分されます。2021年には、機器・キット分野がより大きな市場シェアを占めています。同セグメントは、2022年から2028年にかけて、市場でより高いCAGRを記録すると予測されます。アプリケーションに基づき、市場は疾患スクリーニングと血液型分類に二分されます。疾患スクリーニングセグメントは、2021年に大きな市場シェアを占め、予測期間中に高いCAGRを記録すると予想されます。エンドユーザーに基づいて、市場は血液銀行、病院、診断研究所、血漿分画会社に区分されます。血液銀行セグメントは、2021年に最大の市場シェアを占めました。同セグメントは、2022年から2028年にかけて、世界の輸血診断市場で最も高いCAGRを記録すると予測されます。

COVID-19パンデミックが輸血診断の世界市場に与える影響

COVID-19のパンデミックは、世界中の血液サービス業務に悪影響を及ぼしました。公共の場の回避、社会的距離の取り方、献血活動の中止などにより、ドナーの利用可能性が低下したため、採血に影響を及ぼしました。採血への悪影響は、不十分な血液供給のために輸血の減少につながりました。例えば、オーストラリアのRMIT大学が行った調査「The Impact of COVID-19 on Blood Transfusion Services（COVID-19が輸血サービスに与える影響）。A Systematic Review and Meta-Analysis（系統的レビューとメタ分析）」と題した研究では、同国で平均38％の献血量が減少していることが判明しています。このような血液不足に対処するため、献血を呼びかけ、献血の重要性に対する国民の意識を高め、安全な献血に対する献血者の信頼を得るためのキャンペーンが実施されました。例えば、韓国赤十字血液サービス（KRCBS）の要請により、保健福祉部（MoHW）がマラリア常在国の地域制限を緩和することを承認し、23,000単位以上の全血を収集することができました。

さらに、医師が率先して不要な輸血を抑制する取り組みも行われました。例えば、ABCサイエンスが発表したニュースによると、2022年3月、オーストラリアの医師がオーストラリアの病院で不必要な輸血をしないよう警告を発しました。また、医療行為や手術が制限されたことで、輸血の必要性も減少したのです。したがって、上記の要因や事例は、輸血診断市場が負のCOVID-19の影響を示したことを示しています。

世界の輸血診断市場で活動する企業は、様々な有機的および無機的な戦略を採用しています。有機的な戦略は、主に製品の発売や製品の承認が含まれています。さらに、市場で示された無機的な成長戦略は、買収、共同研究、およびパートナーシップです。これらの成長戦略により、市場参加者は事業を拡大し、地理的プレゼンスを高めることができ、それによって市場全体の成長に貢献することができます。さらに、買収とパートナーシップ戦略は、市場プレーヤーが顧客基盤を強化し、製品ポートフォリオを拡大するのに役立ちます。輸血診断の世界市場における主要企業によるいくつかの重要な発展を以下に列挙します。

2022年7月、Quotient Limitedは、感染症や免疫疾患の管理にバイオマーカーを活用する研究開発企業であるInfYnity Biomarkersとの契約を発表しました。両社は、QuotientのMosaiQソリューションを活用し、感染症検査の安全性と有効性を向上させるために提携します。

2021年11月、ロシュは新しい分子検査装置「cobas 5800 System」をCEマーク受理国で発売すると発表しました。cobas 5800 Systemは、患者検査の増加、診療報酬の複雑化、より多様な検査メニューの必要性など、検査室が直面している課題に対応しながら、有意義でタイムリーな結果を提供することを可能にします。

世界の輸血診断市場に関する報告書を作成するにあたり、主要な一次情報および二次情報として、カナダ国立保健医療研究評議会（NHMRC）、カナダ政府、Kidney Research and Clinical Practice（KRCP）などがあります。

調査対象範囲
インサイトパートナーズの調査報告書ガイダンス
市場セグメンテーション
- 輸血診断の世界市場-製品別
- 輸血診断の世界市場-アプリケーション別
- 輸血診断の世界市場-エンドユーザー別
- 輸血診断の世界市場-地域別

第2章輸血診断市場 - 主要なポイント

第3章調査手法

対象範囲
2次調査
1次調査

第4章輸血診断市場 - 市場情勢

PEST分析
- 北米PEST分析
- 欧州PEST分析
- アジア太平洋地域のPEST分析
- 中東・アフリカPEST分析
- 中南米PEST分析
専門家の見解

第5章輸血診断市場 - 主要な市場力学

市場促進要因
- 慢性疾患の急激な増加
- 臓器移植手術の増加別輸血の必要性
市場抑制要因
- 輸血業務に関連する問題
市場機会
- 新興国におけるヘルスケア支出の増加
- 政府別取り組み強化
今後の動向
- 輸血診断の技術的発展
インパクト分析

第6章輸血診断市場 - 世界分析

輸血診断の世界市場の収益予測と分析
- 輸血診断の世界市場収益と予測・分析
- 輸血診断の世界市場-市場ポテンシャル分析、地域別
輸血診断市場における主要プレイヤーの市場シェア分析
- 企業分析
- 成長戦略分析
- 主要プレイヤーの業績
  - グリフォルスS.A.
  - F.ホフマン・ラ・ロシュ社

第7章輸血診断市場の分析と2028年までの予測 - 製品別

輸血診断市場の製品別収益シェア（2021年、2028年）
機器・キット
試薬

第8章輸血診断市場の分析-用途別

輸血診断市場のアプリケーション別収益シェア（2021年、2028年）
疾患スクリーニング
血液型別

第9章輸血診断市場の分析- エンドユーザー別

輸血診断市場のエンドユーザー別シェア（2021年、2028年）（%）
血液銀行
病院
診断ラボラトリー
血漿分画企業

第10章 2028年までの輸血診断市場収益と予測 - 地域別分析

北米
- 米国
- カナダ
- メキシコ
欧州
- ドイツ
- 英国
- フランス
- イタリア
- スペイン
- その他欧州
アジア太平洋地域
- 中国
- 日本
- インド
- 韓国
- オーストラリア
- その他アジア太平洋地域
中南米
- ブラジル
- アルゼンチン
- その他の中南米地域
中東・アフリカ
- 南アフリカ
- サウジアラビア
- UAE
- その他の中東・アフリカ地域

第11章 COVID-19のパンデミックが輸血診断市場に与える影響

北米
欧州
アジア太平洋地域
中南米
中東とアフリカ

第12章輸血診断市場-業界情勢

輸血診断市場における成長戦略
無機的な成長戦略
有機的成長戦略

第13章企業プロファイル

Grifols, S.A.
F. Hoffmann-La Roche Ltd
Immucor, Inc.
Bio-Rad Laboratories, Inc.
Abbott
Thermo Fisher Scientific Inc.
Ortho Clinical Diagnostics（QuidelOrtho Corporation）
DiaSorin S.p.A.
Quotient Limited
BAG Diagnostics GmbH

第14章付録

インサイト・パートナーズについて
用語解説

図表

List Of Tables

Table 1. North America: Blood Transfusion Diagnostics Market, by Product - Revenue and Forecast to 2028 (US$ Million)
Table 2. North America: Blood Transfusion Diagnostics Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 3. North America: Blood Transfusion Diagnostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 4. US: Blood Transfusion Diagnostics Market, by Product - Revenue and Forecast to 2028 (US$ Million)
Table 5. US: Blood Transfusion Diagnostics Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 6. US: Blood Transfusion Diagnostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 7. Canada: Blood Transfusion Diagnostics Market, by Product - Revenue and Forecast to 2028 (US$ Million)
Table 8. Canada: Blood Transfusion Diagnostics Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 9. Canada: Blood Transfusion Diagnostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 10. Mexico: Blood Transfusion Diagnostics Market, by Product - Revenue and Forecast to 2028 (US$ Million)
Table 11. Mexico: Blood Transfusion Diagnostics Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 12. Mexico: Blood Transfusion Diagnostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 13. Europe: Blood Transfusion Diagnostics Market, by Product - Revenue and Forecast to 2028 (US$ Million)
Table 14. Europe: Blood Transfusion Diagnostics Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 15. Europe: Blood Transfusion Diagnostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 16. Germany: Blood Transfusion Diagnostics Market, by Product - Revenue and Forecast to 2028 (US$ Million)
Table 17. Germany: Blood Transfusion Diagnostics Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 18. Germany: Blood Transfusion Diagnostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 19. UK: Blood Transfusion Diagnostics Market, by Product - Revenue and Forecast to 2028 (US$ Million)
Table 20. UK: Blood Transfusion Diagnostics Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 21. UK: Blood Transfusion Diagnostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 22. France: Blood Transfusion Diagnostics Market, by Product - Revenue and Forecast to 2028 (US$ Million)
Table 23. France: Blood Transfusion Diagnostics Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 24. France: Blood Transfusion Diagnostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 25. Italy: Blood Transfusion Diagnostics Market, by Product - Revenue and Forecast to 2028 (US$ Million)
Table 26. Italy: Blood Transfusion Diagnostics Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 27. Italy: Blood Transfusion Diagnostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 28. Spain: Blood Transfusion Diagnostics Market, by Product - Revenue and Forecast to 2028 (US$ Million)
Table 29. Spain: Blood Transfusion Diagnostics Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 30. Spain: Blood Transfusion Diagnostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 31. Rest of Europe: Blood Transfusion Diagnostics Market, by Product - Revenue and Forecast to 2028 (US$ Million)
Table 32. Rest of Europe: Blood Transfusion Diagnostics Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 33. Rest of Europe: Blood Transfusion Diagnostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 34. Asia Pacific: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million).
Table 35. Asia Pacific: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 36. Asia Pacific: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million)
Table 37. China: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
Table 38. China: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 39. China: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million)
Table 40. Japan: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
Table 41. Japan: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 42. Japan: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million)
Table 43. India: National Estimation of Blood Requirement in India (2018)
Table 44. India: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
Table 45. India: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 46. India: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million)
Table 47. South Korea: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
Table 48. South Korea: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 49. South Korea: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million)
Table 50. Australia: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
Table 51. Australia: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 52. Australia: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million)
Table 53. Rest of Asia Pacific: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
Table 54. Rest of Asia Pacific: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 55. Rest of Asia Pacific: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million)
Table 56. South and Central America Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
Table 57. South and Central America: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 58. South and Central America: Blood Transfusion Diagnostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 59. Brazil: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
Table 60. Brazil: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 61. Brazil: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million)
Table 62. Argentina: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
Table 63. Argentina: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 64. Argentina: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million)
Table 65. Rest of South & Central America: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
Table 66. Rest of South & Central America: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 67. Rest of South & Central America: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million)
Table 68. Middle East & Africa: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
Table 69. Middle East & Africa: Metabolomics Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 70. Middle East & Africa: Blood Transfusion Diagnostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 71. South Africa Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
Table 72. South Africa: Metabolomics Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 73. South Africa: Metabolomics Market Revenue and Forecasts to 2028, By End User (US$ Million)
Table 74. Saudi Arabia: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
Table 75. Saudi Arabia: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 76. Saudi Arabia: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million)
Table 77. UAE: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
Table 78. UAE: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 79. UAE: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million)
Table 80. Rest of Middle East & Africa: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
Table 81. Rest of Middle East & Africa: Metabolomics Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 82. Rest of Middle East & Africa: Metabolomics Market Revenue and Forecasts to 2028, By End User (US$ Million)
Table 83. Recent Inorganic Growth Strategies in the Blood Transfusion Diagnostics Market
Table 84. Recent Organic Growth Strategies in the Blood Transfusion Diagnostics Market
Table 85. Glossary of Terms

List Of Figures

Figure 1. Blood Transfusion Diagnostics Market Segmentation
Figure 2. Blood Transfusion Diagnostics Market - By Geography
Figure 3. Blood Transfusion Diagnostics Market Overview
Figure 4. Instruments and Kits Segment Held Largest Share by Type of Blood Transfusion Diagnostics Market
Figure 5. Asia Pacific to Show Significant Growth During Forecast Period
Figure 6. Blood Transfusion Diagnostics Market, by Geography (US$ Million)
Figure 7. Global Blood Transfusion Diagnostics Market - Leading Country Markets (US$ Million)
Figure 8. Global Blood Transfusion Diagnostics Market, Industry Landscape
Figure 9. North America: PEST Analysis
Figure 10. Europe: PEST Analysis
Figure 11. Asia Pacific: PEST Analysis
Figure 12. Middle East & Africa: PEST Analysis
Figure 13. South & Central America: PEST Analysis
Figure 14. Experts Opinion
Figure 15. Impact Analysis
Figure 16. Global Blood Transfusion Diagnostics Market- Revenue Forecast and Analysis - 2020- 2028
Figure 17. Global Blood Transfusion Diagnostics Market- Revenue Forecast And Analysis - 2021 - 2028
Figure 18. Global Blood Transfusion Diagnostics Market - Market Potential Analysis, By Region
Figure 19. Market Share Analysis of Key Players in Global Blood Transfusion Diagnostics Market
Figure 20. Global Blood Transfusion Diagnostics Market - Comparative Company Analysis
Figure 21. Global Blood Transfusion Diagnostics Market - Growth Strategy Analysis
Figure 22. Market positioning of Key Players in Blood Transfusion Diagnostics Market
Figure 23. Blood Transfusion Diagnostics Market Revenue Share, by Product (2021 and 2028)
Figure 24. Instruments and Kits: Blood Transfusion Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 25. Reagents: Blood Transfusion Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 26. Blood Transfusion Diagnostics Market Revenue Share, by Application (2021 and 2028)
Figure 27. Disease Screening: Blood Transfusion Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 28. Blood Grouping: Blood Transfusion Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 29. Blood Transfusion Diagnostics Market Share, by End User, 2021 and 2028 (%)
Figure 30. Blood Banks: Blood Transfusion Diagnostics Market, Revenue and Forecast to 2028 (US$ Million)
Figure 31. Hospitals: Blood Transfusion Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 32. Diagnostic Laboratories: Blood Transfusion Diagnostics Market, Revenue and Forecast to 2028 (US$ Million)
Figure 33. Plasma Fractionation Companies: Blood Transfusion Diagnostics Market, Revenue and Forecast to 2028 (US$ Million)
Figure 34. North America: Blood Transfusion Diagnostics Market, by Key Country - Revenue (2021) (USD Million)
Figure 35. North America Blood Transfusion Diagnostics Market Revenue and Forecast to 2028 (USD Million)
Figure 36. North America: Blood Transfusion Diagnostics Market, by Country, 2021 & 2028 (%)
Figure 37. US: Blood Transfusion Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 38. Canada: Blood Transfusion Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 39. Mexico: Blood Transfusion Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 40. Europe: Blood Transfusion Diagnostics Market, by Key Country - Revenue (2021) (USD Million)
Figure 41. Europe Blood Transfusion Diagnostics Market Revenue and Forecast to 2028 (USD Million)
Figure 42. Europe: Blood Transfusion Diagnostics Market, by Country, 2021 & 2028 (%)
Figure 43. Germany: Blood Transfusion Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 44. UK: Blood Transfusion Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 45. France: Blood Transfusion Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 46. Italy: Blood Transfusion Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 47. Spain: Blood Transfusion Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 48. Rest of Europe: Blood Transfusion Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 49. Asia Pacific Blood Transfusion Diagnostics Market Overview, by Country (2021)
Figure 50. Asia Pacific: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 51. Asia Pacific: Blood Transfusion Diagnostics Market, by Country, 2021 & 2028 (%)
Figure 52. China: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 53. Japan: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 54. India: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 55. South Korea: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 56. Australia: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 57. Rest of Asia Pacific: Blood Transfusion Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 58. South and Central America Blood Transfusion Diagnostics Market Revenue Overview, by Country, 2021 (US$ Million)
Figure 59. South and Central America Blood Transfusion Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
Figure 60. South and Central America: Blood Transfusion Diagnostics Market, by Country, 2021 & 2028 (%)
Figure 61. Brazil: Blood Transfusion Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
Figure 62. Argentina: Blood Transfusion Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
Figure 63. Rest of the South and Central America: Blood Transfusion Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
Figure 64. Middle East & Africa Blood Transfusion Diagnostics Market Revenue Overview, by Country, 2021 (US$ Million)
Figure 65. Middle East & Africa Blood Transfusion Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
Figure 66. Middle East & Africa: Blood Transfusion Diagnostics Market, by Country, 2021 & 2028 (%)
Figure 67. South Africa: Blood Transfusion Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
Figure 68. Saudi Arabia: Blood Transfusion Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
Figure 69. UAE: Blood Transfusion Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
Figure 70. Rest of the Middle East and Africa: Blood Transfusion Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
Figure 71. Impact of COVID-19 Pandemic in North America Country Markets
Figure 72. Impact of COVID-19 Pandemic on European Country Markets
Figure 73. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
Figure 74. Impact of COVID-19 Pandemic in South and Central American Countries
Figure 75. Impact of COVID-19 Pandemic in Middle East and Africa Country Markets
Figure 76. Growth Strategies in the Blood Transfusion Diagnostics Market

Product Code: TIPRE00005176

The global blood transfusion diagnostics market is expected to grow from US$ 4,096.93 million in 2021 to US$ 6,483.75 million by 2028. It is estimated to grow at a CAGR of 6.9% from 2022 to 2028. The report highlights prevailing trends and factors driving the market growth.

The growth of the global blood transfusion diagnostics market is attributed to the rapid increase in chronic diseases and the need for blood transfusion due to the rise in organ transplant surgeries. However, the problems associated with blood transfusion services hinder the overall market growth.

Blood transfusion diagnostics refers to tests performed on blood and blood components before they are transfused to patients. A blood transfusion is a common procedure in which donated blood or blood components are transfused into the patient's body through an intravenous line (IV). Each unit of blood must undergo blood typing, which refers to identification of blood type and blood screening, including disease detection tests to avoid side effects or transmission of infection. Blood screening before transfusion is performed through instruments, kits, and reagents to identify various diseases, such as HIV, hepatitis B, hepatitis C, Zika, and different viruses and infections.

According to the data published by the National Institute of Cancer Prevention and Research (NICPR) and the Indian Council of Medical Research (ICMR), the yearly prevalence of cancer in India is estimated at ~2.25 million, leading to numerous surgical procedures.

As per a 2019 study, titled "Challenges of blood transfusions in B-thalassemia," approximately 26,000 patients with transfusion-dependent B-thalassemia (TDT) are born every year, and around 90% of these births occur in low- or middle-income countries. Hemoglobinopathies, comprising sickle cell disease, are endemic in Africa, Asia, the Middle East, the Indian subcontinent, and the Mediterranean region. They are currently the most common rare inherited genetic diseases in Europe. Due to migration, hemoglobinopathies have been increasingly common in parts of North America and Northern and Western Europe, where they are not indigenous, and in their indigenous countries of Southern Europe. This led to an increase in the prevalence of B-thalassemia. Approximately 800 patients with thalassemia are registered in the UK National Haemoglobinopathy Registry, with around 500 patients undergoing regular blood transfusions. Therefore, blood transfusion diagnostics are widely used in various surgical procedures, such as cardiac surgery and other invasive procedures.

Chronic diseases, such as cancer, cardiovascular diseases, and renal disorders, are major causes of human death worldwide. These conditions are generally treated via surgical procedures, which are associated with a chance of excessive blood loss. Fresh blood is infused into patients to maintain their blood levels. Blood transfusion diagnostics are used during the blood infusion or reinfusion processes. Hence, the global blood transfusion diagnostics market is rising with the rapid increase in chronic diseases.

Based on product, the global blood transfusion diagnostics market is bifurcated into instruments & kits and reagents. In 2021, the instruments & kits segment held a larger market share. The same segment is expected to register a higher CAGR in the market from 2022 to 2028. Based on application, the market is bifurcated into disease screening and blood grouping. The disease screening segment held a larger market share in 2021 and is expected to register a higher CAGR during the forecast period. Based on end user, the market is segmented into blood banks, hospitals, diagnostic laboratories, and plasma fractionation companies. The blood banks segment held the largest market share in 2021. The same segment is expected to register the highest CAGR in the global blood transfusion diagnostics market from 2022 to 2028.

Impact of COVID-19 Pandemic on Global Blood Transfusion Diagnostics Market

The COVID-19 pandemic negatively impacted blood services operations worldwide. Blood collection was affected due to the decrease in donor availability caused by avoidance of public places, social distancing policies, and cancellation of blood drives. The negative impact on blood collection led to a reduction in blood transfusion due to insufficient blood supply. For instance, a research conducted by RMIT University, Australia, titled "The Impact of COVID-19 on Blood Transfusion Services: A Systematic Review and Meta-Analysis," revealed that the average decrease in blood donations was found to be 38% in the country. To cope with the blood shortage, campaigns were implemented to appeal for blood donation, raise public awareness about the importance of blood donation, and gain donors' confidence in safe blood donation. For instance, upon Korean Red Cross Blood Services' (KRCBS) request, the Ministry of Health and Welfare (MoHW) approved the relaxation of the geographical restrictions regarding indigenous malaria, thus enabling the collection of more than 23,000 units of whole blood.

Furthermore, doctors took the initiative to control unnecessary blood transfusions. For instance, according to the news published by ABC Science, in March 2022, Australian doctors warned against unnecessary blood transfusions in Australian hospitals. Also, as medical and surgical practices were restricted, the need for blood transfusions was decreased too. Thus, the above factors and instances indicate that the blood transfusion diagnostic market witnessed a negative COVID-19 impact.

Various organic and inorganic strategies are adopted by companies operating in the global blood transfusion diagnostics market. The organic strategies mainly include product launches and product approvals. Further, inorganic growth strategies witnessed in the market are acquisitions, collaborations, and partnerships. These growth strategies allow the market players to expand their businesses and enhance their geographic presence, thereby contributing to the overall market growth. Further, acquisition and partnership strategies help the market players strengthen their customer base and expand their product portfolios. A few significant developments by key players in the global blood transfusion diagnostics market are listed below.

In July 2022, Quotient Limited announced an agreement with InfYnity Biomarkers, an R&D firm dedicated to utilizing biomarkers for managing infectious and immunology diseases. The two companies will partner to advance the safety and effectiveness of infectious disease testing by leveraging Quotient's MosaiQ solution.

In November 2021, Roche announced the launch of the cobas 5800 System, a new molecular laboratory instrument, in countries accepting the CE mark. The cobas 5800 System helps address challenges that laboratories are facing from increased patient testing, reimbursement complexities, and the need for a more diverse testing menu while providing meaningful and timely results.

While preparing the report on the global blood transfusion diagnostics market, a few major primary and secondary sources are the National Health and Medical Research Council (NHMRC), the Government of Canada, and the Kidney Research and Clinical Practice (KRCP).

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the blood transfusion diagnostics market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the blood transfusion diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhancing the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

1. Introduction

1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
- 1.3.1 Global Blood Transfusion Diagnostics Market - By Product
- 1.3.2 Global Blood Transfusion Diagnostics Market - By Application
- 1.3.3 Global Blood Transfusion Diagnostics Market - By End User
- 1.3.4 Global Blood Transfusion Diagnostics Market - By Geography

2. Blood Transfusion Diagnostics Market - Key Takeaways

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Blood Transfusion Diagnostics Market - Market Landscape

4.1 Overview
4.2 PEST Analysis
- 4.2.1 North America PEST Analysis
- 4.2.2 Europe PEST Analysis
- 4.2.3 Asia Pacific PEST Analysis
- 4.2.4 Middle East & Africa PEST Analysis
- 4.2.5 South & Central America PEST Analysis
4.3 Experts Opinion

5. Blood Transfusion Diagnostics Market - Key Market Dynamics

5.1 Market Drivers
- 5.1.1 Rapid Increase in Chronic Diseases
- 5.1.2 Need For Blood Transfusion due to Rise in Organ Transplants Surgeries
5.2 Market Restraints
- 5.2.1 Problems associated with Blood Transfusion Services
5.3 Market Opportunities
- 5.3.1 Elevated Healthcare Expenditure in Emerging Economies
- 5.3.2 Growing Initiatives by Governments
5.4 Future Trends
- 5.4.1 Technological Developments in Blood Transfusion Diagnostics
5.5 Impact Analysis

6. Blood Transfusion Diagnostics Market- Global Analysis

6.1 Global Blood Transfusion Diagnostics Market Revenue Forecast and Analysis
- 6.1.1 Global Blood Transfusion Diagnostics Market Revenue Forecast and Analysis
- 6.1.2 Global Blood Transfusion Diagnostics Market - Market Potential Analysis, By Region
6.2 Market Share Analysis of Key Players in Blood Transfusion Diagnostics Market
- 6.2.1 Company Analysis
- 6.2.2 Growth Strategy Analysis
- 6.2.3 Performance of Key Players
  - 6.2.3.1 Grifols S.A.
  - 6.2.3.2 F. Hoffmann-La Roche Ltd

7. Blood Transfusion Diagnostics Market Analysis and Forecasts To 2028 - By Product

7.1 Overview
7.2 Blood Transfusion Diagnostics Market Revenue Share, by Product (2021 and 2028)
7.3 Instruments and Kits
- 7.3.1 Overview
- 7.3.2 Instruments and Kits: Blood Transfusion Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
7.4 Reagents
- 7.4.1 Overview
- 7.4.2 Reagents: Blood Transfusion Diagnostics Market - Revenue and Forecast to 2028 (USD Million)

8. Blood Transfusion Diagnostics Market Analysis - By Application

8.1 Overview
8.2 Blood Transfusion Diagnostics Market Revenue Share, by Application (2021 and 2028)
8.3 Disease Screening
- 8.3.1 Overview
- 8.3.2 Disease Screening: Blood Transfusion Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
8.4 Blood Grouping
- 8.4.1 Overview
- 8.4.2 Blood Grouping: Blood Transfusion Diagnostics Market - Revenue and Forecast to 2028 (USD Million)

9. Blood Transfusion Diagnostics Market Analysis - By End User

9.1 Overview
9.2 Blood Transfusion Diagnostics Market Share, by End User, 2021 and 2028, (%)
9.3 Blood Banks
- 9.3.1 Overview
- 9.3.2 Blood Banks: Blood Transfusion Diagnostics Market, Revenue and Forecast to 2028 (US$ Million)
9.4 Hospitals
- 9.4.1 Overview
- 9.4.2 Hospitals: Blood Transfusion Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.5 Diagnostic Laboratories
- 9.5.1 Overview
- 9.5.2 Diagnostic Laboratories: Blood Transfusion Diagnostics Market, Revenue and Forecast to 2028 (US$ Million)
9.6 Plasma Fractionation Companies
- 9.6.1 Overview
- 9.6.2 Plasma Fractionation Companies: Blood Transfusion Diagnostics Market, Revenue and Forecast to 2028 (US$ Million)

10. Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028 - Geographical Analysis

10.1 North America: Blood Transfusion Diagnostics Market
- 10.1.1 Overview
- 10.1.2 North America: Blood Transfusion Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
- 10.1.3 North America: Blood Transfusion Diagnostics Market, by Product, 2019-2028 (USD Million)
- 10.1.4 North America: Blood Transfusion Diagnostics Market, by Application, 2019-2028 (USD Million)
- 10.1.5 North America: Blood Transfusion Diagnostics Market, by End User, 2019-2028 (USD Million)
- 10.1.6 North America: Blood Transfusion Diagnostics Market, by Country, 2021 & 2028 (%)
  - 10.1.6.1 US: Blood Transfusion Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
    - 10.1.6.1.1 US: Blood Transfusion Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
    - 10.1.6.1.2 US: Blood Transfusion Diagnostics Market, by Product, 2019-2028 (USD Million)
    - 10.1.6.1.3 US: Blood Transfusion Diagnostics Market, by Application, 2019-2028 (USD Million)
    - 10.1.6.1.4 US: Blood Transfusion Diagnostics Market, by End User, 2019-2028 (USD Million)
  - 10.1.6.2 Canada: Blood Transfusion Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
    - 10.1.6.2.1 Canada: Blood Transfusion Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
    - 10.1.6.2.2 Canada: Blood Transfusion Diagnostics Market, by Product, 2019-2028 (USD Million)
    - 10.1.6.2.3 Canada: Blood Transfusion Diagnostics Market, by Application, 2019-2028 (USD Million)
    - 10.1.6.2.4 Canada: Blood Transfusion Diagnostics Market, by End User, 2019-2028 (USD Million)
  - 10.1.6.3 Mexico: Blood Transfusion Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
    - 10.1.6.3.1 Mexico: Blood Transfusion Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
    - 10.1.6.3.2 Mexico: Blood Transfusion Diagnostics Market, by Product, 2019-2028 (USD Million)
    - 10.1.6.3.3 Mexico: Blood Transfusion Diagnostics Market, by Application, 2019-2028 (USD Million)
    - 10.1.6.3.4 Mexico: Blood Transfusion Diagnostics Market, by End User, 2019-2028 (USD Million)
10.2 Europe: Blood Transfusion Diagnostics Market
- 10.2.1 Overview
- 10.2.2 Europe: Blood Transfusion Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
- 10.2.3 Europe: Blood Transfusion Diagnostics Market, by Product, 2019-2028 (USD Million)
- 10.2.4 Europe: Blood Transfusion Diagnostics Market, by Application, 2019-2028 (USD Million)
- 10.2.5 Europe: Blood Transfusion Diagnostics Market, by End User, 2019-2028 (USD Million)
- 10.2.6 Europe: Blood Transfusion Diagnostics Market, by Country, 2021 & 2028 (%)
  - 10.2.6.1 Germany: Blood Transfusion Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
    - 10.2.6.1.1 Germany: Blood Transfusion Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
    - 10.2.6.1.2 Germany: Blood Transfusion Diagnostics Market, by Product, 2019-2028 (USD Million)
    - 10.2.6.1.3 Germany: Blood Transfusion Diagnostics Market, by Application, 2019-2028 (USD Million)
    - 10.2.6.1.4 Germany: Blood Transfusion Diagnostics Market, by End User, 2019-2028 (USD Million)
  - 10.2.6.2 UK: Blood Transfusion Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
    - 10.2.6.2.1 UK: Blood Transfusion Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
    - 10.2.6.2.2 UK: Blood Transfusion Diagnostics Market, by Product, 2019-2028 (USD Million)
    - 10.2.6.2.3 UK: Blood Transfusion Diagnostics Market, by Application, 2019-2028 (USD Million)
    - 10.2.6.2.4 UK: Blood Transfusion Diagnostics Market, by End User, 2019-2028 (USD Million)
  - 10.2.6.3 France: Blood Transfusion Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
    - 10.2.6.3.1 France: Blood Transfusion Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
    - 10.2.6.3.2 France: Blood Transfusion Diagnostics Market, by Product, 2019-2028 (USD Million)
    - 10.2.6.3.3 France: Blood Transfusion Diagnostics Market, by Application, 2019-2028 (USD Million)
    - 10.2.6.3.4 France: Blood Transfusion Diagnostics Market, by End User, 2019-2028 (USD Million)
  - 10.2.6.4 Italy: Blood Transfusion Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
    - 10.2.6.4.1 Italy: Blood Transfusion Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
    - 10.2.6.4.2 Italy: Blood Transfusion Diagnostics Market, by Product, 2019-2028 (USD Million)
    - 10.2.6.4.3 Italy: Blood Transfusion Diagnostics Market, by Application, 2019-2028 (USD Million)
    - 10.2.6.4.4 Italy: Blood Transfusion Diagnostics Market, by End User, 2019-2028 (USD Million)
  - 10.2.6.5 Spain: Blood Transfusion Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
    - 10.2.6.5.1 Spain: Blood Transfusion Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
    - 10.2.6.5.2 Spain: Blood Transfusion Diagnostics Market, by Product, 2019-2028 (USD Million)
    - 10.2.6.5.3 Spain: Blood Transfusion Diagnostics Market, by Application, 2019-2028 (USD Million)
    - 10.2.6.5.4 Spain: Blood Transfusion Diagnostics Market, by End User, 2019-2028 (USD Million)
  - 10.2.6.6 Rest of Europe: Blood Transfusion Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
    - 10.2.6.6.1 Rest of Europe: Blood Transfusion Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
    - 10.2.6.6.2 Rest of Europe: Blood Transfusion Diagnostics Market, by Product, 2019-2028 (USD Million)
    - 10.2.6.6.3 Rest of Europe: Blood Transfusion Diagnostics Market, by Application, 2019-2028 (USD Million)
    - 10.2.6.6.4 Rest of Europe: Blood Transfusion Diagnostics Market, by End User, 2019-2028 (USD Million)
10.3 Asia Pacific Blood Transfusion Diagnostics Market Revenue and Forecasts To 2028
- 10.3.1 Overview
- 10.3.2 Asia Pacific Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
- 10.3.3 Asia Pacific: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
- 10.3.4 Asia Pacific: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)
- 10.3.5 Asia Pacific: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million)
- 10.3.6 Asia Pacific: Blood Transfusion Diagnostics Market, by Country, 2021 & 2028 (%)
  - 10.3.6.1 China: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
    - 10.3.6.1.1 Overview
    - 10.3.6.1.2 China: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
    - 10.3.6.1.3 China: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
    - 10.3.6.1.4 China: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)
    - 10.3.6.1.5 China: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million)
  - 10.3.6.2 Japan: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
    - 10.3.6.2.1 Overview
    - 10.3.6.2.2 Japan: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
    - 10.3.6.2.3 Japan: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
    - 10.3.6.2.4 Japan: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)
    - 10.3.6.2.5 Japan: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million)
  - 10.3.6.3 India Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
    - 10.3.6.3.1 Overview
    - 10.3.6.3.2 India: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
    - 10.3.6.3.3 India: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
    - 10.3.6.3.4 India: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)
    - 10.3.6.3.5 India: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million)
  - 10.3.6.4 South Korea: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
    - 10.3.6.4.1 Overview
    - 10.3.6.4.2 South Korea: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
    - 10.3.6.4.3 South Korea: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
    - 10.3.6.4.4 South Korea: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)
    - 10.3.6.4.5 South Korea: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million)
  - 10.3.6.5 Australia: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
    - 10.3.6.5.1 Overview
    - 10.3.6.5.2 Australia: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
    - 10.3.6.5.3 Australia: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
    - 10.3.6.5.4 Australia: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)
    - 10.3.6.5.5 Australia: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million)
  - 10.3.6.6 Rest of Asia Pacific: Blood Transfusion Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.3.6.6.1 Overview
    - 10.3.6.6.2 Rest of Asia Pacific: Blood Transfusion Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.3.6.6.3 Rest of Asia Pacific: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
    - 10.3.6.6.4 Rest of Asia Pacific: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)
    - 10.3.6.6.5 Rest of Asia Pacific: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million)
10.4 South and Central America Blood Transfusion Diagnostics Market
- 10.4.1 Overview
- 10.4.2 South and Central America Blood Transfusion Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
- 10.4.3 South and Central America Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
- 10.4.4 South and Central America: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)
- 10.4.5 South and Central America: Blood Transfusion Diagnostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
- 10.4.6 South and Central America: Blood Transfusion Diagnostics Market, by Country, 2021 & 2028 (%)
  - 10.4.6.1 Brazil: Blood Transfusion Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
    - 10.4.6.1.1 Overview
    - 10.4.6.1.2 Brazil Blood Transfusion Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
    - 10.4.6.1.3 Brazil: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
    - 10.4.6.1.4 Brazil: Blood Transfusion Diagnostics Market Revenue and Forecasts To 2028, By Application (US$ Million)
    - 10.4.6.1.5 Brazil: Blood Transfusion Diagnostics Market Revenue and Forecasts To 2028, By End User (US$ Million)
  - 10.4.6.2 Argentina: Blood Transfusion Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
    - 10.4.6.2.1 Overview
    - 10.4.6.2.2 Argentina Blood Transfusion Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
    - 10.4.6.2.3 Argentina: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
    - 10.4.6.2.4 Argentina: Blood Transfusion Diagnostics Market Revenue and Forecasts To 2028, By Application (US$ Million)
    - 10.4.6.2.5 Argentina: Blood Transfusion Diagnostics Market Revenue and Forecasts To 2028, By End User (US$ Million)
  - 10.4.6.3 Rest of the South and Central America: Blood Transfusion Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
    - 10.4.6.3.1 Overview
    - 10.4.6.3.2 Rest of the South and Central America Blood Transfusion Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
    - 10.4.6.3.3 Rest of South & Central America: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
    - 10.4.6.3.4 Rest of South & Central America: Blood Transfusion Diagnostics Market Revenue and Forecasts To 2028, By Application (US$ Million)
    - 10.4.6.3.5 Rest of South & Central America: Blood Transfusion Diagnostics Market Revenue and Forecasts To 2028, By End User (US$ Million)
10.5 Middle East & Africa Blood Transfusion Diagnostics Market
- 10.5.1 Overview
- 10.5.2 Middle East & Africa Blood Transfusion Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
- 10.5.3 Middle East & Africa: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
- 10.5.4 Middle East & Africa: Metabolomics Market Revenue and Forecasts to 2028, By Application (US$ Million)
- 10.5.5 Middle East & Africa: Blood Transfusion Diagnostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
- 10.5.6 Middle East & Africa: Blood Transfusion Diagnostics Market, by Country, 2021 & 2028 (%)
  - 10.5.6.1 South Africa: Blood Transfusion Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
    - 10.5.6.1.1 Overview
    - 10.5.6.1.2 South Africa Blood Transfusion Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
    - 10.5.6.1.3 South Africa: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
    - 10.5.6.1.4 South Africa: Metabolomics Market Revenue and Forecasts To 2028, By Application (US$ Million)
    - 10.5.6.1.5 South Africa: Metabolomics Market Revenue and Forecasts To 2028, By End User (US$ Million)
  - 10.5.6.2 Saudi Arabia: Blood Transfusion Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
    - 10.5.6.2.1 Overview
    - 10.5.6.2.2 Saudi Arabia Blood Transfusion Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
    - 10.5.6.2.3 Saudi Arabia: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
    - 10.5.6.2.4 Saudi Arabia: Blood Transfusion Diagnostics Market Revenue and Forecasts To 2028, By Application (US$ Million)
    - 10.5.6.2.5 Saudi Arabia: Blood Transfusion Diagnostics Market Revenue and Forecasts To 2028, By End User (US$ Million)
  - 10.5.6.3 UAE: Blood Transfusion Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
    - 10.5.6.3.1 Overview
    - 10.5.6.3.2 UAE: Blood Transfusion Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
    - 10.5.6.3.3 UAE: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
    - 10.5.6.3.4 UAE: Blood Transfusion Diagnostics Market Revenue and Forecasts To 2028, By Application (US$ Million)
    - 10.5.6.3.5 UAE: Blood Transfusion Diagnostics Market Revenue and Forecasts To 2028, By End User (US$ Million)
  - 10.5.6.4 Rest of the Middle East and Africa: Blood Transfusion Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
    - 10.5.6.4.1 Overview
    - 10.5.6.4.2 Rest of the Middle East and Africa Blood Transfusion Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
    - 10.5.6.4.3 Rest of Middle East & Africa: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
    - 10.5.6.4.4 Rest of Middle East & Africa: Metabolomics Market Revenue and Forecasts To 2028, By Application (US$ Million)
    - 10.5.6.4.5 Rest of Middle East & Africa: Metabolomics Market Revenue and Forecasts To 2028, By End User (US$ Million)

11. Impact of COVID-19 Pandemic on Blood Transfusion Diagnostics Market

11.1 North America: Impact Assessment of COVID-19 Pandemic
11.2 Europe: Impact Assessment of COVID-19 Pandemic
11.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
11.4 South and Central America: Impact Assessment of COVID-19 Pandemic
11.5 Middle East and Africa: Impact Assessment of COVID-19 Pandemic

12. Blood Transfusion Diagnostics Market-Industry Landscape

12.1 Overview
12.2 Growth Strategies in the Blood Transfusion Diagnostics Market
12.3 Inorganic Growth Strategies
- 12.3.1 Overview
12.4 Organic Growth Strategies
- 12.4.1 Overview

13. Company Profiles

13.1 Grifols, S.A.
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 F. Hoffmann-La Roche Ltd
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Immucor, Inc.
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Bio-Rad Laboratories, Inc.
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Abbott
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Thermo Fisher Scientific Inc.
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Ortho Clinical Diagnostics (QuidelOrtho Corporation)
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 DiaSorin S.p.A.
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Quotient Limited
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 BAG Diagnostics GmbH
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments

14. Appendix

14.1 About The Insight Partners
14.2 Glossary of Terms

輸血診断市場の2028年までの予測-製品、アプリケーション、エンドユーザー別の世界分析

Blood Transfusion Diagnostics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product, Application, and End User

目次

第1章イントロダクション

第2章輸血診断市場 - 主要なポイント

第3章調査手法

第4章輸血診断市場 - 市場情勢

第5章輸血診断市場 - 主要な市場力学

第6章輸血診断市場 - 世界分析

第7章輸血診断市場の分析と2028年までの予測 - 製品別

第8章輸血診断市場の分析-用途別

第9章輸血診断市場の分析- エンドユーザー別

第10章 2028年までの輸血診断市場収益と予測 - 地域別分析

第11章 COVID-19のパンデミックが輸血診断市場に与える影響

第12章輸血診断市場-業界情勢

第13章企業プロファイル

第14章付録

List Of Tables

List Of Figures

Reasons to Buy:

Table Of Contents

1. Introduction

2. Blood Transfusion Diagnostics Market - Key Takeaways

3. Research Methodology

4. Blood Transfusion Diagnostics Market - Market Landscape

5. Blood Transfusion Diagnostics Market - Key Market Dynamics

6. Blood Transfusion Diagnostics Market- Global Analysis

7. Blood Transfusion Diagnostics Market Analysis and Forecasts To 2028 - By Product

8. Blood Transfusion Diagnostics Market Analysis - By Application

9. Blood Transfusion Diagnostics Market Analysis - By End User

10. Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028 - Geographical Analysis

11. Impact of COVID-19 Pandemic on Blood Transfusion Diagnostics Market

12. Blood Transfusion Diagnostics Market-Industry Landscape

13. Company Profiles

14. Appendix

輸血診断市場の2028年までの予測-製品、アプリケーション、エンドユーザー別の世界分析

Blood Transfusion Diagnostics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product, Application, and End User

目次

第1章 イントロダクション

第2章 輸血診断市場 - 主要なポイント

第3章 調査手法

第4章 輸血診断市場 - 市場情勢

第5章 輸血診断市場 - 主要な市場力学

第6章 輸血診断市場 - 世界分析

第7章 輸血診断市場の分析と2028年までの予測 - 製品別

第8章 輸血診断市場の分析-用途別

第9章 輸血診断市場の分析- エンドユーザー別

第10章 2028年までの輸血診断市場収益と予測 - 地域別分析

第11章 COVID-19のパンデミックが輸血診断市場に与える影響

第12章 輸血診断市場-業界情勢

第13章 企業プロファイル

第14章 付録

List Of Tables

List Of Figures

Reasons to Buy:

Table Of Contents

1. Introduction

2. Blood Transfusion Diagnostics Market - Key Takeaways

3. Research Methodology

4. Blood Transfusion Diagnostics Market - Market Landscape

5. Blood Transfusion Diagnostics Market - Key Market Dynamics

6. Blood Transfusion Diagnostics Market- Global Analysis

7. Blood Transfusion Diagnostics Market Analysis and Forecasts To 2028 - By Product

8. Blood Transfusion Diagnostics Market Analysis - By Application

9. Blood Transfusion Diagnostics Market Analysis - By End User

10. Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028 - Geographical Analysis

11. Impact of COVID-19 Pandemic on Blood Transfusion Diagnostics Market

12. Blood Transfusion Diagnostics Market-Industry Landscape

13. Company Profiles

14. Appendix

第1章イントロダクション

第2章輸血診断市場 - 主要なポイント

第3章調査手法

第4章輸血診断市場 - 市場情勢

第5章輸血診断市場 - 主要な市場力学

第6章輸血診断市場 - 世界分析

第7章輸血診断市場の分析と2028年までの予測 - 製品別

第8章輸血診断市場の分析-用途別

第9章輸血診断市場の分析- エンドユーザー別

第12章輸血診断市場-業界情勢

第13章企業プロファイル

第14章付録